{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T13:00:56Z","timestamp":1789563656059,"version":"build-2803163510"},"reference-count":38,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2014,10,23]],"date-time":"2014-10-23T00:00:00Z","timestamp":1414022400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosntds.org"],"crossmark-restriction":false},"short-container-title":["PLoS Negl Trop Dis"],"DOI":"10.1371\/journal.pntd.0003253","type":"journal-article","created":{"date-parts":[[2014,10,23]],"date-time":"2014-10-23T21:08:53Z","timestamp":1414098533000},"page":"e3253","update-policy":"https:\/\/doi.org\/10.1371\/journal.pntd.corrections_policy","source":"Crossref","is-referenced-by-count":49,"title":["Identification and Characterization of Hundreds of Potent and Selective Inhibitors of Trypanosoma brucei Growth from a Kinase-Targeted Library Screening Campaign"],"prefix":"10.1371","volume":"8","author":[{"given":"Rosario","family":"Diaz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra A.","family":"Luengo-Arratta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo\u00e3o D.","family":"Seixas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuele","family":"Amata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Devine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Cordon-Obras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domingo I.","family":"Rojas-Barros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Jimenez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatima","family":"Ortega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrinia","family":"Crouch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gonzalo","family":"Colmenarejo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose Maria","family":"Fiandor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose Julio","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuela","family":"Berlanga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Gonzalez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pilar","family":"Manzano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"Navarro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael P.","family":"Pollastri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2014,10,23]]},"reference":[{"key":"ref1","unstructured":"Sustaining the drive to overcome the global impact of neglected tropical diseases. World Health Organization. <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/apps.who.int\/iris\/bitstream\/10665\/77950\/1\/9789241564540_eng.pdf\" xlink:type=\"simple\">http:\/\/apps.who.int\/iris\/bitstream\/10665\/77950\/1\/9789241564540_eng.pdf<\/ext-link>. Accessed: 22 April 2014"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"e1151","DOI":"10.1371\/journal.pntd.0001151","article-title":"SCYX-7158, an Orally-Active Benzoxaborole for the Treatment of Stage 2 Human African Trypanosomiasis","volume":"5","author":"RT Jacobs","year":"2011","journal-title":"PLoS Negl Trop Dis"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1086\/522982","article-title":"Nifurtimox-Eflornithine Combination Therapy for Second-Stage Trypanosoma brucei gambiense Sleeping Sickness: A Randomized Clinical Trial in Congo","volume":"45","author":"G Priotto","year":"2007","journal-title":"Clin Infect Dis"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"5602","DOI":"10.1128\/AAC.00246-11","article-title":"Antitrypanosomal activity of fexinidazole, a new oral nitroimidazole drug candidate for treatment of sleeping sickness","volume":"55","author":"M Kaiser","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"e923","DOI":"10.1371\/journal.pntd.0000923","article-title":"Fexinidazole\u2014a new oral nitroimidazole drug candidate entering clinical development for the treatment of sleeping sickness","volume":"4","author":"E Torreele","year":"2010","journal-title":"PLoS Negl Trop Dis"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1038\/nrd2144","article-title":"Innovative lead discovery strategies for tropical diseases","volume":"5","author":"S Nwaka","year":"2006","journal-title":"Nat Rev Drug Discov"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1002\/cmdc.201200428","article-title":"Fueling Open-Source Drug Discovery: 177 Small-Molecule Leads against Tuberculosis","volume":"8","author":"L Ballell","year":"2013","journal-title":"ChemMedChem"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1038\/nature09107","article-title":"Thousands of chemical starting points for antimalarial lead identification","volume":"465","author":"FJ Gamo","year":"2010","journal-title":"Nature"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1021\/ml200135p","article-title":"An Invitation to Open Innovation in Malaria Drug Discovery: 47 Quality Starting Points from the TCAMS","volume":"2","author":"F Calder\u00f3n","year":"2011","journal-title":"ACS Medicinal Chemistry Letters"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.4155\/fmc.11.92","article-title":"Target repurposing for neglected diseases","volume":"3","author":"MP Pollastri","year":"2011","journal-title":"Future Med Chem"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.4155\/fmc.11.77","article-title":"Phosphodiesterase inhibitors as a new generation of antiprotozoan drugs: exploiting the benefit of enzymes that are highly conserved between host and parasite","volume":"3","author":"T Seebeck","year":"2011","journal-title":"Future Med Chem"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1016\/j.bmcl.2012.01.072","article-title":"Inhibitors of human histone deacetylase with potent activity against the African trypanosome Trypanosoma brucei","volume":"22","author":"JM Kelly","year":"2012","journal-title":"Bioorg Med Chem Lett"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.ejmech.2012.07.038","article-title":"The human Aurora kinase inhibitor danusertib is a lead compound for anti-trypanosomal drug discovery via target repurposing","volume":"62","author":"SO Ochiana","year":"2013","journal-title":"Eur J Med Chem"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"e1297","DOI":"10.1371\/journal.pntd.0001297","article-title":"The susceptibility of trypanosomatid pathogens to PI3\/mTOR kinase inhibitors affords a new opportunity for drug repurposing","volume":"5","author":"R Diaz-Gonzalez","year":"2011","journal-title":"PLoS Negl Trop Dis"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"e56150","DOI":"10.1371\/journal.pone.0056150","article-title":"Lapatinib-binding protein kinases in the african trypanosome: identification of cellular targets for kinase-directed chemical scaffolds","volume":"8","author":"S Katiyar","year":"2013","journal-title":"PLoS ONE"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"e1017","DOI":"10.1371\/journal.pntd.0001017","article-title":"<italic>Trypanosoma brucei<\/italic> glycogen synthase kinase-3, a target for anti-trypanosomal drug development: A public-private partnership to identify novel leads","volume":"5","author":"RO Oduor","year":"2011","journal-title":"PLoS Negl Trop Dis"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"4834","DOI":"10.1021\/jm500361r","article-title":"Establishment of a structure-activity relationship of the 1H-imidazo[4,5-c]quinoline-based kinase inhibitor NVP-BEZ235 as a lead for African sleeping sickness","volume":"57","author":"JD Seixas","year":"2014","journal-title":"J Med Chem"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.bbapap.2005.08.018","article-title":"Protein kinases as drug targets in trypanosomes and Leishmania","volume":"1754","author":"C Naula","year":"2005","journal-title":"Biochim Biophys Acta"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1186\/1471-2164-6-127","article-title":"Comparative analysis of the kinomes of three pathogenic trypanosomatids: <italic>Leishmania major<\/italic>, <italic>Trypanosoma brucei<\/italic> and <italic>Trypanosoma cruzi<\/italic>","volume":"6","author":"M Parsons","year":"2005","journal-title":"BMC Genomics"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/clpt.2012.236","article-title":"Phenotypic vs. target-based drug discovery for first-in-class medicines","volume":"93","author":"DC Swinney","year":"2013","journal-title":"Clin Pharmacol Ther"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.jpba.2005.11.009","article-title":"Evaluation of the chemiluminescent nitrogen detector for solubility determinations to support drug discovery","volume":"41","author":"SN Bhattachar","year":"2006","journal-title":"J Pharm Biomed Anal"},{"key":"ref22","first-page":"2022","article-title":"Chromatographic hydrophobicity index by fast-gradient RP-HPLC: A high-throughput alternative to log P\/log D. Anal Chem","volume":"69","author":"K Valko","year":"1997"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.1002\/jps.10494","article-title":"Fast gradient HPLC method to determine compounds binding to human serum albumin. Relationships with octanol\/water and immobilized artificial membrane lipophilicity","volume":"92","author":"K Valko","year":"2003","journal-title":"J Pharm Sci"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1002\/1520-6017(200008)89:8<1085::AID-JPS13>3.0.CO;2-N","article-title":"Rapid-gradient HPLC method for measuring drug interactions with immobilized artificial membrane: comparison with other lipophilicity measures","volume":"89","author":"K Valko","year":"2000","journal-title":"J Pharm Sci"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"30","DOI":"10.2174\/187231211794455262","article-title":"A comparative study of the CYP450 inhibition potential of marketed drugs using two fluorescence based assay platforms routinely used in the pharmaceutical industry","volume":"5","author":"M Kajbaf","year":"2011","journal-title":"Drug Metab Lett"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"e57888","DOI":"10.1371\/journal.pone.0057888","article-title":"Profile of the GSK Published Protein Kinase Inhibitor Set Across ATP-Dependent and-Independent Luciferases: Implications for Reporter-Gene Assays","volume":"8","author":"P Dranchak","year":"2013","journal-title":"PLoS ONE"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0001-706X(97)00079-X","article-title":"The Alamar Blue assay to determine drug sensitivity of African trypanosomes (T.b. rhodesiense and T.b. gambiense) in vitro","volume":"68","author":"B Raz","year":"1997","journal-title":"Acta Trop"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1002\/cbic.200400211","article-title":"High-throughput screening for kinase inhibitors","volume":"6","author":"O von Ahsen","year":"2005","journal-title":"Chembiochem"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"521","DOI":"10.2174\/1386207054867274","article-title":"HTS quality control and data analysis: a process to maximize information from a high-throughput screen","volume":"8","author":"R Padmanabha","year":"2005","journal-title":"Comb Chem High Throughput Screen"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/S1359-6446(04)03069-7","article-title":"Ligand efficiency: a useful metric for lead selection","volume":"9","author":"AL Hopkins","year":"2004","journal-title":"Drug Discov Today"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1021\/ml500015r","article-title":"Case Study of Small Molecules As Antimalarials: 2-Amino-1-phenylethanol (APE) Derivatives","volume":"5","author":"MJ Chaparro","year":"2014","journal-title":"ACS Medicinal Chemistry Letters"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"5992","DOI":"10.1016\/j.bmcl.2013.08.030","article-title":"The thermodynamic basis for the use of lipophilic efficiency (LipE) in enthalpic optimizations","volume":"23","author":"MD Shultz","year":"2013","journal-title":"Bioorg Med Chem Lett"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"5980","DOI":"10.1016\/j.bmcl.2013.08.029","article-title":"Setting expectations in molecular optimizations: Strengths and limitations of commonly used composite parameters","volume":"23","author":"MD Shultz","year":"2013","journal-title":"Bioorg Med Chem Lett"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1038\/nrd2445","article-title":"The influence of drug-like concepts on decision-making in medicinal chemistry","volume":"6","author":"PD Leeson","year":"2007","journal-title":"Nat Rev Drug Discov"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1021\/cn100008c","article-title":"Moving beyond rules: The development of a central nervous system multiparameter optimization (CNS MPO) approach to enable alignment of druglike properties","volume":"1","author":"TT Wager","year":"2010","journal-title":"ACS Chem Neurosci"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"e1932","DOI":"10.1371\/journal.pntd.0001932","article-title":"A static-cidal assay for Trypanosoma brucei to aid hit prioritisation for progression into drug discovery programmes","volume":"6","author":"M De Rycker","year":"2012","journal-title":"PLoS Negl Trop Dis"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"340","DOI":"10.2174\/1568026613666131127160819","article-title":"Seeding collaborations to advance kinase science with the GSK Published Kinase Inhibitor Set (PKIS)","volume":"14","author":"DH Drewry","year":"2014","journal-title":"Curr Top Med Chem"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1002\/cmdc.200600168","article-title":"In silico ADMET traffic lights as a tool for the prioritization of HTS hits","volume":"1","author":"M Lobell","year":"2006","journal-title":"ChemMedChem"}],"container-title":["PLoS Neglected Tropical Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pntd.0003253","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T11:16:20Z","timestamp":1589022980000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0003253"}},"subtitle":[],"editor":[{"given":"Timothy G.","family":"Geary","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2014,10,23]]},"references-count":38,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2014,10,23]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pntd.0003253","relation":{},"ISSN":["1935-2735"],"issn-type":[{"value":"1935-2735","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,10,23]]}}}